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Informatics in Neuro-critical Care: New Ideas for Big Data 
ABSTRACT 
Purpose of review 
Big data is the new hype in business and healthcare. Data storage and processing has become cheap, fast, 
and easy. Business analysts and scientists are trying to design methods to mine these data for hidden 
knowledge. Neuro-critical care is a field that typically produces large amounts of patient-related data, and 
these data are increasingly being digitized and stored. This review will try to look beyond the hype, and 
focus on possible applications in neuro-intensive care amenable to Big Data research that can potentially 
improve patient care. 
Recent findings 
The first challenge in Big Data research will be the development of large, multicenter and high quality 
databases. These databases could be used to further investigate recent findings from mathematical 
models, developed in smaller datasets. Randomized clinical trials (RCTs) and Big Data research are 
complementary. Big Data research might be used to identify subgroups of patients that could benefit most 
from a certain intervention, or can be an alternative in areas where RCTs are not possible.  
Summary  
The processing and the analysis of the large amount of patient-related information stored in clinical 
databases is beyond normal human cognitive ability. Big Data research applications have the potential to 
discover new medical knowledge, and improve care in the neuro-intensive care unit.  
Keywords 
Big data; neuro-critical care; neuro-informatics; data mining; predictive modelling 
INTRODUCTION   
‘Big data’ refers to the current speed and volume at which computerized data are generated by web 
applications and by the digitization of information that was previously available on paper only. 
Additionally, it refers to the improvements in technology that enable to store, process, and analyze these 
data [1]. Informally, these characteristics are referred to as the ‘the three V’s of big data: Volume, Velocity, 
and Variety [2]. Surprisingly, nowadays it is more cost-effective to invest in data storage than in cleaning 
old databases [3]. However, the lack of standardization and the uncertain data quality has added a fourth 
V for ‘Veracity’ to the definition. Finally, Big Data is useless without a clear vision and knowledge of the 
‘Value’ it will bring to business or healthcare [1]. Together, Volume, Velocity, Variety, Veracity and Value 
are the five V’s of Big Data (table 1). 
The intensive care unit (ICU) is a very data rich environment, where patients are monitored continuously 
and receive vital support [4]. This is especially true for the neuro-critical care unit, where radiological 
imaging and specific invasive and non-invasive bedside monitors, further contribute to the huge amounts 
of data collected [5–7]. Digitized medical and pharmaceutical data, when integrated, are an enormous and 
continuous data source, which is dwarfed by the further inclusion of data from genomics [8] or 
microbiomics [9]. In a structured healthcare database, the relationship between specific clinical 
characteristics of patients, interventions, and outcomes can be investigated at a scale that was not possible 
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before. Data from non-medical sources such as social networks, wearables that track daily activity and 
fitness, and social security or government databases could be integrated and used to assess pre-morbid 
status or post-hospitalization functional outcomes. Theoretically, a continuously adapting healthcare 
system could be designed [10] that uses these huge amounts of data to forecast the best treatment action 
or prognosis for each patient. Furthermore, such a system could contribute to medical knowledge and 
generate new research hypotheses. The technological feat of setting up such an advanced healthcare 
system is further challenged by proprietary, legal and privacy issues. Most importantly, the true challenge 
of big data research will begin after these practical obstacles have been overcome: how will these data be 
turned into information, knowledge and wisdom? [11] The naïve approach of over-confidence in the 
quality of data, and blindly applying black box techniques to address research questions, is an 
oversimplification that can possibly lead to dubious results and spurious interpretations.  A famous quote 
by Dr. Isaac Kohane, Big Data pioneer and co-director of the Center for Biomedical Informatics at Harvard 
Medical School, is a good summary of this challenge: “You really need to know something about medicine. 
If statistics lie, then Big Data can lie in a very, very big way”. [12]  
Big Data research is still in its infancy, and clinical applications specifically for the neuro-ICU are currently 
lacking. Therefore, this review focuses on possible applications in the neuro-ICU amenable to Big Data 
research, and will discuss perspectives, opportunities and pitfalls.  
CLINICAL DATA SYSTEMS AND DATABASES IN NEURO-CRITICAL CARE: STATUS AND CHALLENGES 
Big Data research in the neuro-ICU will require the creation of multicenter, multi-patient and 
multidimensional databases. ICU’s and neuro-ICU’s are increasingly implementing electronic healthcare 
records [13]. However, standardization is lacking at many levels. First, specific to the neuro-ICU is the use 
of brain multimodality monitoring (MMM) [6], the simultaneous collection of data from diverse monitors 
in a single patient [14], such as intracranial pressure (ICP), cerebral perfusion pressure (CPP), 
cerebrovascular autoregulation, brain tissue oxygenation, cerebral blood flow (CBF), microdialysis, or 
electro-encephalography (EEG). Different centers have different preferences in the use of medical devices 
and/or software systems, and there is no universal standard for device communication [15], nor for 
synchronization between these devices [16]. There are no guidelines on the optimal resolution in which to 
store time series data. Inherent to the use of continuous non-validated monitoring data are artifacts and 
missing data, for which several automated methods for de-noising and imputation have been proposed 
[15] including the use of advanced data mining techniques [17]. Second, the diagnosis and management 
of acute brain injury relies heavily on repeated neuro-imaging, such as CT, MRI, or more advanced 
methods. Apart from a lack of standardization on timing, frequency, and indications, summarizing this high 
resolution visual information is challenging. Third, genomics data are likely to enter the neuro-ICU in the 
upcoming years [18,19].  Fourth, the modalities, frequency, and timing of outcome assessment are not 
standardized and might vary between centers, with the further limitation of a proportion patients who are 
inevitably lost to follow-up. For traumatic brain injury (TBI), Maas et al. have introduced recommendations 
to standardize the process of data collection [20]. Figure 1 is a schematic representation of the relevant 
healthcare information that could be collected during and after the admission of a patient to the neuro-
ICU.  
Existing clinical databases suffer from multiple problems. The International Mission for Prognosis And 
Clinical Trial (IMPACT) database, contains records of 9205 ICU patients collected between 1984-1997, but 
includes only few imaging data and no monitoring data [21]. The BrainIT database includes demographic, 
clinical data, and minute-by-minute monitoring data as well as outcome data, but only from a very small 
sample of 202 patients with TBI, collected in 18 European centers between July 2003 and June 2005 [22]. 
Some centers are storing the data of their own patients, but do not provide access. The MIMIC II database 
is likely the most amenable for Big Data: it is a large open-access clinical database, however from a single 
not specifically neuro-ICU center. The MIMIC II database contains demographics, physiological data, 
medications and outcome recorded from more than 30,000 ICU patients admitted to Beth Israel 
Deaconess Medical Center (Boston, MA) from 2001 to 2008 [23]. The International Initiative for Traumatic 
Brain Injury Research (InTBIR) has developed the Federal Interagency TBI Research (FITBIR) Informatics 
System platform, allowing data sharing across the entire TBI community [24]. FITBIR aims to collect patient-
level phenotypic, genomic, and imaging information. Additionally, embedded in the network of InTBIR, 
Center-TBI is currently collecting highly detailed information from 1800 ICU patients, including imaging 
and long-term outcomes [25].  
BIG DATA RESEARCH AND THE MULTIMODALITY MONITORING PLATFORM: PERSPECTIVES AND 
POSSIBLE APPLICATIONS 
Accumulating evidence suggests that the information obtained from MMM could be used for patient-
specific therapy [7]. However, there is little guidance on what and when to monitor. Furthermore, the 
interpretation of the amount of sophisticated data produced by MMM is beyond normal human cognitive 
ability. There is a crucial need for a better understanding of the complex variability and interactions 
between physiological variables to transform them into usable information that can be integrated into 
patient care. [26] In relatively small mainly retrospective clinical studies, advanced mathematical 
techniques, and machine learning models, have been applied to investigate the treatment thresholds, the 
underlying pathophysiology, or the interactions between monitored parameter. Although they have 
resulted in physiologically plausible hypotheses, it would be very difficult or even impossible to study these 
novel insights in randomized controlled trials (RCTs). Big Data offers new insights and the possibility to 
extract knowledge from raw data, a process called knowledge discovery [27,28]. In what follows, work in 
relatively small datasets that could benefit from Big Data is discussed.  
Intracranial pressure: towards individualized thresholds?  
ICP monitoring is probably the most commonly applied invasive brain-specific monitor in the neuro-ICU, 
especially in TBI. The recommendations of the Brain Trauma Foundation guidelines to monitor ICP in every 
salvageable patient with severe TBI with intracranial abnormalities, and to treat ICP at a threshold of 20 
mmHg [29] have been challenged by RCTs that failed to demonstrate the benefit of such a strategy [30,31]. 
Instead, patient-specific thresholds may be preferable. In a retrospective single center cohort study, Vik et 
al. have demonstrated that the area under the ICP curve above 20 mmHg, or the “dose” of intracranial 
hypertension, was associated with poor outcome [32]. Lazaridis et al. could demonstrate that 
individualized doses of intracranial hypertension, based on the cerebrovascular autoregulatory status, 
were stronger predictors of death than doses derived from fixed thresholds of 20 and 25 mm Hg [33]. By 
examining the univariate association between episodes of elevated ICP of increasing intensity and duration 
with outcome, Güiza et al. were able to visualize the pressure and time burden of ICP [34]. In addition, 
they were able to demonstrate that the ability to tolerate episodes of increased ICP depends on the age, 
the CPP and the cerebrovascular autoregulatory status of the patients.  
Cerebrovascular autoregulation.  
Cerebrovascular autoregulation is the mechanism that maintains a stable cerebral blood flow despite 
fluctuations in CPP. Failure of cerebrovascular autoregulation is observed in acute brain injury due to a 
variety of causes, such as TBI [35], subarachnoid hemorrhage (SAH) [36], stroke [37], cardiac arrest [38], 
and sepsis [39]. Such failure is associated with worse outcomes, and represents a challenge for 
hemodynamic optimization. Several methods have been proposed to assess autoregulation in a non-
continuous way [36,40]. Marek Czosnyka and colleagues have pioneered the design of computational 
methods to assess cerebrovascular motor activity [41]. Their pressure reactivity index (PrX) calculates a 
moving correlation coefficient between arterial blood pressure (ABP) and ICP, using a moving window of 
continuous waveform data [42]. Using the PrX, the optimal CPP when autoregulation is most active can be 
calculated [43]. In a retrospective study, an actual CPP close to this optimal CPP, was associated with better 
outcomes in TBI patients [44]. The low-frequency autoregulation index (LAx) [45] was instead designed 
based on minute-by-minute data and was able to confirm in a retrospective study, that actual CPP close 
to optimal CPP was associated with better outcomes in TBI. Unfortunately, optimal CPP cannot be 
calculated continuously for all patients [46]. A single-center pilot study has shown the feasibility of 
targeted CPP management at bedside in a small adult population [47].  
Early warning models for secondary injury. 
Prevention and treatment of secondary injury is the main goal of neuro-critical care. Identifying early signs 
of neurological deterioration is a challenge in the neuro-ICU. Early warnings could allow for preventive 
instead of reactive management, and may result in a more timely administration of therapy. In a 
retrospective study TBI patients with diffuse injury were found to likely benefit from different CPP therapy 
than those with mass lesions [48]. Predictive models could be important tools for clinicians to guide 
decision making. Early signs of imminent intracranial hypertension in severe TBI can be detected through 
advanced time series analysis of ICP and ABP combined in a machine learning model. It is striking that loss 
of cerebrovascular autoregulation was one of the main predictors in these models [49], a finding that has 
been confirmed in other studies [50,51]. In SAH, heart rate variability analysis was used to predict delayed 
cerebral ischemia and infections [52]. These predictive models are not yet available at the bedside, and 
their further development, implementation and validation could be done in a Big Data research platform.  
Prediction of clinical outcome.  
In the neuro-ICU, prognostic information can be used to guide family counseling, assess treatment 
effectiveness and allow efficient design of RCTs. The Glasgow Coma Score [53] and the Marshall CT score 
have been used to identify patients at risk for worse outcome, or as stratification for clinical trials [54]. The 
IMPACT [55] and CRASH (Corticosteroid Randomization After Significant Head Injury) [56] models have 
been rigorously designed and validated externally [57–60]. Time-series analysis of physiological 
monitoring during the first 24 hours in the ICU could improve the performance of these models [49]. 
Developing such models involves more than the naïve application of a black box algorithms, and should be 
constructed using proper statistical methods for selection of relevant features [61] with input from domain 
experts [62], and likewise following proper internal and external validation [63]. In order to determine the 
clinical value of a predictive model, not only the discrimination, but also the calibration, followed by a 
decision curves analysis, should be done [64] .  
BIG DATA ANALYSIS AND CLINICAL RESEARCH  
Most RCTs on neuro-protective strategies in the neuro-critical care unit have been negative [65]. The exact 
reasons for this are diverse, including insufficient preclinical experimental work, incomplete 
(patho)physiological understanding or methodological flaws. Likewise, the primary endpoints might not 
have been sensitive enough, or might have missed a link with pathophysiology. In general, it proves to be 
very challenging to design RCTs that take into account population heterogeneity, and to delineate those 
subgroups that might benefit most from a certain intervention. On the one hand, randomizing patients is 
still the best way to establish a causal inference between an intervention and outcome. On the other hand, 
ethical, financial or compliance constraints can limit the feasibility of translating a research question into 
a RCT. Big data has been proposed as a complement to RCTs [66,67]. Adaptive clinical trials could be a way 
forward, where a trial is designed in such a way that it can ‘learn’ to identify subgroups or conditions in 
which the intervention could be beneficial. For those research questions where an RCT is not feasible, Big 
Data research could be an alternative.  
CONCLUSIONS 
Big Data can give a new perspective on the many challenges that we face in medicine and neuro-critical 
care. Researchers and clinicians need to be aware of the opportunities, but at the same time will need to 
look beyond the hype. Proper data organization and structuring, together with the design of appropriate 
analytic tools, will be of key importance [68]. In addition to these data analysis modalities, new ways of 
presenting individualized predictions and treatment recommendations to healthcare providers will have 
to be designed and validated [69]. Hence, the processing and analysis of the large amount of patient-
related information stored in well-designed databases has the potential to improve neuro-critical care. 
KEYPOINTS 
 Big Data research should begin with a clear understanding of the value it will bring.   
 Existing databases in neuro-critical care are not well suited for Big Data applications. A particular 
focus should be made to develop large, multicenter, high resolution and quality databases. 
 Big Data hold a great promise to personalize patient care through clinical decision support tools 
based on robustly designed machine learning models. 
 Big Data research is not an easy alternative to difficult clinical trials.  
 RCTs and Big Data are complementary; the latter can identify patient groups that may benefit 
more from RCTs, or can be used to address specific research questions when RCTs are not 
feasible.  
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Figure 1
 
Figure 1: Schematic representaion of the relevant healthcare information that could be 
collected during and after the admission of a patient to the neuro-ICU. Patient specific 
information, can refer to demographic data, age and gender, medical history, co-morbitities, 
but also to the data collected during his ICU stay such as monitoring data. These data are 
typically collected in the electronic health record of the ICU, called the patient data 
management system or PDMS. Data from the PDMS, together with the radiological 
examinations and lab data, are stored in the hospitalization record of the patient. Ideally, 
post discharge data from outpatient visits, reports from revalidation, social security or 
healthcare insurance information regarding degree of invalidity and dependence, as well as 
the civil registry where mortality data can be retrieved, should also be added tot he post-
discharge data of the patient.   
Figure 1 legend
Table1: The five V’s of big data 
Volume The large amount of data generated 
Velocity The speed at which data are generated, transmitted, and processed 
Variety The different types and formats of data 
 Structured and unstructured data 
 Text 
 Numeric data 
 Images, video, audio 
 … 
Veracity The reliability, quality, accuracy, or trustworthiness of the data 
Value The use of these data for a specific benefit , or the potential ability to turn data into value  
Table 1: Big data is often defined as the three, four, or five V’s. The importance of the fifth V, Value, is 
being increasingly recognized.  
Table 1 including legend
